Abstract
Acute promyelocytic leukemia (APL) is part of the group of acute myeloid leukemias and is characterized by having the best long-term prognosis. On the other hand, its initial treatment is characterized by high morbidity and early mortality. The occurrence of a severe hemorrhagic syndrome at the time of diagnosis, in a significant number of patients, results in the most relevant aspect of …